CDC is conducting a new pilot on samples it is collecting as part of its Traveler-based Genomic Surveillance (TGS) program that will provide early detection of flu, RSV, and select other respiratory viruses, in addition to SARS-CoV-2.
A study released today from the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration shows that, among high school students, current (past 30-day) use of any tobacco product declined during 2022-2023 (16.5% to 12.6%), primarily driven by a decline in e-cigarette use (14.1% to 10.0%).
The Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH) announced today the launch of Impact Wellbeing.
Transcript: Health Workers Face a Mental Health Crisis
More than double the number of health workers reported harassment at work in 2022 than in 2018. This may include threats, bullying, verbal abuse, or other actions from patients and coworkers that create a hostile work environment. This finding has important implications for health worker mental health, according to a new CDC Vital Signs report.
New diagnoses of six major cancer types in the United States fell abruptly in early 2020, coinciding with the start of the COVID-19 pandemic, according to findings from part 2 of the latest Annual Report to the Nation on the Status of Cancer.
Today, CDC recommended the first respiratory syncytial virus (RSV) vaccine for pregnant people to protect their newborn from severe RSV illness. RSV is the leading cause of hospitalization for U.S. infants. This new vaccine, Pfizer’s bivalent RSVpreF vaccine (trade name Abrysvo TM), has been shown to reduce the risk of RSV hospitalization for babies by…
Read more
On September 19, 2022, CDC announced the recipients of 13 funding awards to establish a first-of-its-kind national network, the Outbreak Analytics and Disease Modeling Network (OADMN).
New population data from 2022 show 22 states have an adult obesity prevalence at or above 35%, compared to 19 states in 2021, according to data from the Centers for Disease Control and Prevention (CDC).
In April, HHS announced the ‘HHS Bridge Access Program For COVID-19 Vaccines and Treatments Program'(“Program”) to maintain broad access to COVID-19 vaccines for millions of uninsured Americans.
